Healthcare provider profile · identity verified

Gregory J Sperle, MD

Family Practice · PARK RAPIDS, MN · NPI 1720029390

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	256	69
Atorvastatin Calcium	Atorvastatin Calcium	243	83
Levothyroxine Sodium	Levothyroxine Sodium	228	69
Amlodipine Besylate	Amlodipine Besylate	199	70
Omeprazole	Omeprazole	197	55
Lisinopril	Lisinopril	191	55
Gabapentin	Gabapentin	186	35
Losartan Potassium	Losartan Potassium	179	51
Metoprolol Tartrate	Metoprolol Tartrate	175	34
Hydrochlorothiazide	Hydrochlorothiazide	149	52
Furosemide	Furosemide	127	26
Donepezil Hcl	Donepezil Hcl	119	suppressed
Metformin Hcl	Metformin Hcl	116	27
Rosuvastatin Calcium	Rosuvastatin Calcium	115	34
Famotidine	Famotidine	105	18
Simvastatin	Simvastatin	105	42
Duloxetine Hcl	Duloxetine Hcl	101	19
Warfarin Sodium	Warfarin Sodium	96	32
Potassium Chloride	Potassium Chloride	95	23
Memantine Hcl	Memantine Hcl	82	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	80	19
Tamsulosin Hcl	Tamsulosin Hcl	73	28
Clopidogrel	Clopidogrel Bisulfate	63	15
Mirtazapine	Mirtazapine	61	suppressed
Trazodone Hcl	Trazodone Hcl	56	20
Pravastatin Sodium	Pravastatin Sodium	54	19
Allopurinol	Allopurinol	52	20
Carvedilol	Carvedilol	52	14
Digoxin	Digoxin	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	20
Glipizide	Glipizide	47	17
Eliquis	Apixaban	45	suppressed
Montelukast Sodium	Montelukast Sodium	43	13
Albuterol Sulfate Hfa	Albuterol Sulfate	40	21
Spironolactone	Spironolactone	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Torsemide	Torsemide	39	suppressed
Sertraline Hcl	Sertraline Hcl	38	11
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Finasteride	Finasteride	30	suppressed
Verapamil Er	Verapamil Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Atenolol	Atenolol	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Myrbetriq	Mirabegron	23	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Risperidone	Risperidone	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Benazepril Hcl	Benazepril Hcl	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Topiramate	Topiramate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Baclofen	Baclofen	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Entacapone	Entacapone	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Brinzolamide	Brinzolamide	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error